The global Opioid Addiction and Dependence Market is poised to exhibit a robust revenue compound annual growth rate (CAGR) over the projected timeframe. This growth can be attributed to the escalating prevalence of opioid addiction and dependence, a leading cause of mortality largely associated with prescription drug overdoses. The Centers for Disease Control and Prevention (CDC) has estimated that around 2.1 million Americans suffered from opioid use disorder in 2016. The transition from opioid abuse to addiction is driven by drug-induced alterations in the brain.
Among the frequently abused opioids are Oxycodone, codeine, hydrocodone, morphine, and fentanyl. This escalating crisis is further exacerbated by the perilous long-term consequence of opioid use—physical dependency—resulting in withdrawal symptoms upon abrupt cessation. This alarming rise in opioid addiction cases each year underscores its severe implications on public health.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5428
The term "opioids" encompasses substances capable of interacting with brain opioid receptors, encompassing derivatives from poppy seeds and semi- and fully synthetic substances with comparable effects. Opioids, such as morphine, fentanyl, and tramadol, are commonly prescribed to alleviate pain. However, opioid addiction, a chronic condition, can impose grave repercussions on an individual's health, relationships, and finances. A distinctive feature of opioid addiction is the compulsive urge to consume opioid medications even when medically unnecessary. This addiction risk is not limited to illicit use; even prescribed opioids can carry substantial addiction potential, as they are often misused or shared with others. This addiction poses life-threatening health risks, notably overdose. Overdosing on opioids, such as fentanyl, can result in respiratory depression and even death.
Market Drivers: The mounting population dependent on drugs is expected to drive the global opioid dependence treatment market. Annually, approximately 2 million Americans, along with an estimated 15 million individuals worldwide, grapple with heroin and prescription opiate abuse. Opioid abuse and addiction are fueled by the prevalence of severe chronic diseases like cancer, cardiovascular ailments, injuries, and other conditions leading to enduring pain managed by opioid consumption. However, this pain management strategy carries the risk of addiction. Additionally, escalating dependency coupled with abrupt discontinuation can trigger withdrawal symptoms.
The World Health Organization (WHO) highlights the global impact of drug-related deaths, attributing over 70% of these deaths to opioids. In 2020, more than 30% of these fatalities were attributed to overdose, with opioids being involved in 70.6% of drug overdose deaths in the United States in 2019, according to the CDC.
Market Restraints: The lack of awareness, high treatment costs, and limited treatment options for opioid addiction are likely to hamper market expansion. The adverse effects stemming from medications employed in treating opioid addiction constitute a pivotal factor constraining the global market's growth. These medications can trigger side effects such as nausea, vomiting, abdominal discomfort, respiratory problems, joint and muscle pain, and constipation.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/5428
Geographic Market Landscape: Dominant Market Share: North America is anticipated to command the largest revenue share during the forecast period, chiefly driven by the increasing use of synthetic opioids like fentanyl in the United States. With over 2 million Americans and an estimated 15 million people globally affected by prescription opioid and heroin misuse annually, addiction and misuse of opioids are reaching alarming proportions. Opioid overdoses claimed over 20,000 lives due to prescription opioids and 13,000 lives due to heroin overdoses in the U.S. in 2016. The majority of drug overdose fatalities in Americans under 50 years are attributed to opioids, making them the primary cause of such deaths. The North American region is projected to witness market growth due to the expanding number of drug addicts and the rise in youth engaging in drug misuse and dependency.
Rapidly Expanding Region: The Asia Pacific region is forecasted to exhibit the highest growth rate during the forecast period, followed by Europe. In a notable example, a report from the National Center for Biotechnology Information revealed that India's illicit opiate use rate is double the global average. In 2018, India was estimated to have 4 million opioid users and 1 million opioid-dependent individuals.
Key Market Trends and Innovations: The adoption of buprenorphine patches as an effective treatment for opioid use disorder is a noteworthy trend in the global opioid addiction treatment market. Buprenorphine patches represent an advanced approach to treating opioid use disorder. These transdermal patches offer a more user-friendly drug delivery method that reduces pain and can be self-administered by patients, distinguishing them from conventional modalities like injections. Buprenorphine patches also hold promise as an immediate treatment substitute for those struggling with opioid use disorder.
Organic and Inorganic Strategies: Prominent Market Players: Several key players are driving innovation and progress in the opioid addiction treatment market. These include Opiant Pharmaceuticals, Pear Therapeutics, Foresee Pharma, Indivior Plc., Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., BioDelivery Sciences International Inc., Collegium Pharmaceutical, Inc., Viatris Inc., Pfizer, Inc., and Hikma Pharmaceuticals Plc.
Start-ups and Innovators: Start-ups and innovators like Pannex Therapeutics are also contributing to advancements in the field of opioid addiction treatment.
Report Insights and Superiority: This comprehensive report provides historical data, forecasts, and revenue growth analysis at the global, regional, and country levels from 2019 to 2030. It offers industry insights, trends, consumption patterns, and detailed analyses for each major country and segment. Beyond that, the report delves into industry analysis, competitive landscapes, company financials, and impact assessments.
Categorizing by Product Type, Route of Administration, Drug Class, End-Use, and Distribution Channel, the report offers a deep understanding of market dynamics and potential opportunities for market growth across regions such as North America (U.S., Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Benelux, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific), Latin America (Brazil, Rest of Latin America), and Middle East Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East Africa).
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5428
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Linear Accelerators for Radiation Market
Supraventricular Tachycardia Treatment Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
